88MED

88MED operates as a medical wellness clinic in Omaha, Nebraska, under the direction of Dr. Darin Jackson, offering a focused combination of metabolic medicine, hormone optimization, and laser-based aesthetic procedures. The clinic's treatment model integrates semaglutide peptide therapy for weight management with bioidentical hormone replacement therapy (BHRT) and advanced laser services, creating a multi-system approach to age management and body composition. Patients schedule in-person consultations at the Omaha location, where treatment plans are developed based on individual metabolic profiles and aesthetic objectives.

Semaglutide, a GLP-1 receptor agonist peptide, forms the foundation of 88MED's weight loss protocols. This peptide works by regulating appetite signaling, slowing gastric emptying, and improving insulin sensitivity, making it particularly effective for patients with metabolic resistance or those who have struggled with conventional calorie-restriction approaches. Dr. Jackson's protocols pair semaglutide administration with metabolic monitoring to track body composition changes and adjust dosing based on patient response. The clinic's BHRT services address hormonal imbalances that often accompany weight gain and metabolic dysfunction, using bioidentical formulations customized to patient hormone panels. This dual approach targets both the symptomatic weight concerns and underlying endocrine factors that contribute to metabolic slowdown.

Dr. Darin Jackson brings clinical expertise in integrative wellness medicine to 88MED's patient care model. His approach emphasizes diagnostic clarity before treatment initiation, using laboratory assessment to identify hormone deficiencies, metabolic markers, and contraindications before prescribing peptide or hormone therapies. Patients work directly with Dr. Jackson during in-person visits in Omaha, where treatment adjustments are made based on ongoing monitoring rather than fixed protocols. This physician-directed model ensures that semaglutide dosing, hormone replacement regimens, and aesthetic treatment plans remain responsive to individual patient progress and tolerance.

The patient experience at 88MED centers on in-clinic consultations where treatment goals are defined and progress is tracked through measurable outcomes. Patients receiving semaglutide therapy return for follow-up visits to assess weight trends, side effect management, and metabolic response, with dosage titration performed under medical supervision. Those pursuing laser aesthetic services—including tattoo removal and skin rejuvenation—undergo treatment sessions using clinic-owned laser technology, with energy settings and treatment intervals customized to skin type and desired results. The clinic's review feedback consistently references the effectiveness of laser equipment, the clarity of pricing structures, and the alignment between patient goals and achieved outcomes, indicating a results-focused practice environment.

88MED distinguishes itself in the Omaha medical wellness market through its combination of peptide-based metabolic therapy and aesthetic laser services under unified medical oversight. Unlike wellness centers that refer aesthetic procedures externally or aesthetic clinics that avoid metabolic medicine, 88MED provides both service categories within a single practice, allowing patients to address body composition, hormonal health, and cosmetic concerns through coordinated treatment planning. The clinic's exclusive in-person consultation model ensures that Dr. Jackson maintains direct clinical oversight of all peptide prescriptions and laser procedures, a structure that prioritizes safety and individualized care over volume-based telemedicine models. For Omaha-area patients seeking medically supervised weight loss with semaglutide or hormone optimization paired with aesthetic enhancement, 88MED offers a physician-led alternative to franchise wellness centers and standalone aesthetic practices.